Skip to main content

Bispecific antibodies in cancer immunotherapy

Intervista a Omid Hamid By 5 Dicembre 2022No Comments
Dai congressi

We met in Naples – at the Immunotherapy Bridge Congress – Omid Hamid, Director of Immunotherapy and Translational Research at The Angeles Clinic and Research Institute of Los Angeles, that gave us an overview of the possible applications in oncology of one the most interesting and promising product in the field of biotechnology, bispecific antibodies.